Tablets and capsules remain the gold standard in oral drug delivery, prized for their patient compliance, manufacturing scalability, and precise dosing. However, beneath their familiar exterior lies a complex developmental journey. Transitioning a novel molecule or a complex generic formulation from the benchtop into scalable, commercial-grade solid oral dosage forms is fraught with scientific,...
The pharmaceutical landscape is heavily driven by the demand for affordable, accessible, and high-quality medicines. When a brand-name drug's patent protection expires, generic drug manufacturers have the opportunity to introduce equivalent therapeutic options to the market. However, proving that a generic tablet is just as safe, effective, and high-performing as the innovator product requires...
The journey of a novel therapeutic molecule from an initial discovery concept to a commercially viable pharmaceutical product is one of the most complex, resource-intensive, and strictly regulated endeavors in modern science. Historically, the drug development lifecycle has been characterized by high attrition rates, escalating costs, and lengthy timelines.
A critical factor separating...
The United Arab Emirates (UAE) has rapidly evolved into a thriving hub for clinical research in the Middle East. Backed by forward-thinking regulatory frameworks from the Ministry of Health and Prevention (MoHAP), the Department of Health (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA), the nation offers a highly sophisticated healthcare infrastructure, diverse patient populations, and...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek